Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Not Yet Recruiting

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

NCT07553767

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +26 more
Locations: Shulan (Hangzhou) Hospital Hangzhou, Zhejiang, China

Ningbo Medical Center Lihuili Hospital Ningbo, Zhejiang, China

Ningbo Mingzhou Hospital (Affiliated to Zhejiang University) Ningbo, Zhejiang, China

Ningbo No.2 Hospital Ningbo, Zhejiang, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial

NCT07543783

Conditions: Adebrelimab (SHR-1316), Adenocarcinoma, Bevacizumab, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

NCT07543510

Conditions: Adenocarcinoma, Atezolizumab Plus Bevacizumab, Carcinoma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

NCT07544121

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +28 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma

NCT07487402

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

NCT07537946

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases

NCT07537959

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma

NCT07535840

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy

NCT07537777

Conditions: Adenocarcinoma, Anlotinib, Benmelstobart, +14 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Denosumab Strategy for Liver Cancer With Bone Metastases

NCT07537972

Conditions: Adenocarcinoma, Bone Metastases, Carcinoma, +10 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Liver Neoplasms

Liver Neoplasms trial results

Related conditions